[Metabolic syndrome and cerebrovascular disease: evidence in their treatment]

R J Rodríguez-Kú1

  • 1Departamento de Neurofisiología, Hospital General Regional numero 1, Instituto Mexicano del Seguro Social, Mérida, Yucatán, México. renneuro@hotmail.com

Revista De Neurologia
|March 6, 2009
PubMed

Insights

Metabolic syndrome significantly increases stroke risk. Comprehensive management of its components, including lifestyle changes and medication, is crucial for stroke prevention and reducing disability worldwide.

Area of Science:

  • Neurology
  • Cardiovascular Medicine
  • Metabolic Disorders

Background:

  • Stroke is a leading global cause of death and disability.
  • Metabolic syndrome, a cluster of conditions including obesity, hypertension, dyslipidemia, and hyperglycemia, is increasingly linked to atherosclerosis and stroke.
  • While age-related, stroke has modifiable risk factors associated with metabolic syndrome.

Purpose of the Study:

  • To analyze the individual and combined impact of metabolic syndrome components on stroke risk.
  • To propose evidence-based medical management strategies for stroke prevention in patients with metabolic syndrome.

Main Methods:

  • Review of current clinical evidence on metabolic syndrome and stroke.
  • Analysis of risk factors associated with individual components and the overall metabolic syndrome.
  • Development of treatment recommendations based on evidence.

Main Results:

  • Metabolic syndrome and its individual components are significant risk factors for stroke.
  • Simultaneous presence of metabolic syndrome components exacerbates stroke risk.
  • Evidence supports a multi-faceted approach to managing metabolic syndrome.

Conclusions:

  • A comprehensive treatment strategy targeting metabolic syndrome is proposed.
  • Lifestyle modifications (exercise, weight reduction, diet) are foundational.
  • Pharmacological interventions should be considered when necessary, guided by clinical evidence.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Cushing Syndrome II: Pathophysiology01:19

Cushing Syndrome II: Pathophysiology

Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features of the...
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Cerebral Edema ll: Pathophysiology01:22

Cerebral Edema ll: Pathophysiology

Vasogenic edema is a major form of cerebral edema characterized by abnormal accumulation of fluid in the brain’s extracellular space due to disruption of the blood–brain barrier (BBB). The BBB is a specialized structure composed of endothelial cells connected by tight junctions, supported by astrocytic endfeet and a basement membrane. Under normal conditions, it tightly regulates the movement of ions, proteins, and solutes between the bloodstream and brain parenchyma. When this barrier loses...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.